These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25131591)

  • 1. Role of α-synuclein in neurodegeneration: implications for the pathogenesis of Parkinson's disease.
    Yu S; Chan P
    Essays Biochem; 2014; 56():125-35. PubMed ID: 25131591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.
    Bellucci A; Navarria L; Zaltieri M; Missale C; Spano P
    Brain Res; 2012 Jan; 1432():95-113. PubMed ID: 22153624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of α-synuclein in neurotransmission and synaptic plasticity.
    Cheng F; Vivacqua G; Yu S
    J Chem Neuroanat; 2011 Dec; 42(4):242-8. PubMed ID: 21167933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease.
    Xie W; Chung KK
    J Neurochem; 2012 Jul; 122(2):404-14. PubMed ID: 22537068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of α-Synuclein Oligomers in Parkinson's Disease.
    Du XY; Xie XX; Liu RT
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
    Sato H; Kato T; Arawaka S
    Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent anion channel involved in the α-synuclein-induced dopaminergic neuron toxicity in rats.
    Lu L; Zhang C; Cai Q; Lu Q; Duan C; Zhu Y; Yang H
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):170-8. PubMed ID: 23291291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
    Luna E; Luk KC
    FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.
    Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P
    Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of alpha-synuclein aggregation by dopamine: a review.
    Leong SL; Cappai R; Barnham KJ; Pham CL
    Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein and Parkinson's disease.
    Recchia A; Debetto P; Negro A; Guidolin D; Skaper SD; Giusti P
    FASEB J; 2004 Apr; 18(6):617-26. PubMed ID: 15054084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
    Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
    Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.